Amdocs Weighted Average Shares vs Cost of Revenue Analysis

DOX
 Stock
  

USD 88.95  1.36  1.55%   

Amdocs financial indicator trend analysis is way more than just evaluating Amdocs Limited prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs Limited is a good investment. Please check the relationship between Amdocs Weighted Average Shares and its Cost of Revenue accounts. Continue to Investing Opportunities.

Weighted Average Shares vs Cost of Revenue

Weighted Average Shares vs Cost of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Limited Weighted Average Shares account and Cost of Revenue. At this time, the significance of the direction appears to have pay attention.
The correlation between Amdocs' Weighted Average Shares and Cost of Revenue is -0.96. Overlapping area represents the amount of variation of Weighted Average Shares that can explain the historical movement of Cost of Revenue in the same time period over historical financial statements of Amdocs Limited, assuming nothing else is changed. The correlation between historical values of Amdocs' Weighted Average Shares and Cost of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Weighted Average Shares of Amdocs Limited are associated (or correlated) with its Cost of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost of Revenue has no effect on the direction of Weighted Average Shares i.e., Amdocs' Weighted Average Shares and Cost of Revenue go up and down completely randomly.

Correlation Coefficient

-0.96
Relationship DirectionNegative 
Relationship StrengthSignificant

Weighted Average Shares

The weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPS]; determined based on the timing of issuance of shares or units in the period.

Cost of Revenue

Cost of Revenue is found on Amdocs Limited income statement and represents the costs associated with goods and services Amdocs provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. The aggregate cost of goods produced and sold and services rendered during the reporting period.
Most indicators from Amdocs fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Investing Opportunities.Amdocs Net Cash Flow Business Acquisitions and Disposals is fairly stable at the moment as compared to the past year. Amdocs reported Net Cash Flow Business Acquisitions and Disposals of 168.24 Million in 2021. Enterprise Value over EBIT is likely to rise to 15.21 in 2022, whereas Selling General and Administrative Expense is likely to drop slightly above 557.8 M in 2022.
 2019 2020 2021 2022 (projected)
Consolidated Income497.84 M688.37 M791.63 M673.75 M
Direct Expenses2.76 B2.81 B2.53 B2.34 B

Amdocs fundamental ratios Correlations

0.150.24-0.550.44-0.80.71-0.380.06-0.220.330.550.160.310.050.030.290.79-0.66-0.79
0.15-0.29-0.66-0.15-0.550.10.090.04-0.26-0.21-0.11-0.33-0.18-0.26-0.05-0.160.150.25-0.12
0.24-0.29-0.30.96-0.30.66-0.9-0.870.740.930.930.980.80.940.860.960.7-0.6-0.49
-0.55-0.66-0.3-0.50.94-0.70.460.340.01-0.33-0.53-0.24-0.21-0.26-0.33-0.44-0.680.160.73
0.44-0.150.96-0.5-0.530.8-0.92-0.80.620.890.980.940.750.890.810.960.81-0.63-0.65
-0.8-0.55-0.30.94-0.53-0.790.480.220.1-0.37-0.6-0.23-0.28-0.2-0.25-0.43-0.80.380.81
0.710.10.66-0.70.8-0.79-0.75-0.480.110.710.820.580.450.580.50.740.87-0.58-0.79
-0.380.09-0.90.46-0.920.48-0.750.85-0.67-0.86-0.88-0.87-0.69-0.86-0.91-0.91-0.780.510.56
0.060.04-0.870.34-0.80.22-0.480.85-0.85-0.85-0.74-0.84-0.73-0.87-0.96-0.83-0.550.320.31
-0.22-0.260.740.010.620.10.11-0.67-0.850.620.560.780.720.730.860.640.26-0.28-0.08
0.33-0.210.93-0.330.89-0.370.71-0.86-0.850.620.910.840.860.810.790.860.8-0.69-0.59
0.55-0.110.93-0.530.98-0.60.82-0.88-0.740.560.910.870.830.810.740.910.88-0.73-0.75
0.16-0.330.98-0.240.94-0.230.58-0.87-0.840.780.840.870.730.960.860.950.59-0.51-0.39
0.31-0.180.8-0.210.75-0.280.45-0.69-0.730.720.860.830.730.630.690.680.71-0.76-0.56
0.05-0.260.94-0.260.89-0.20.58-0.86-0.870.730.810.810.960.630.880.970.52-0.36-0.3
0.03-0.050.86-0.330.81-0.250.5-0.91-0.960.860.790.740.860.690.880.860.54-0.32-0.32
0.29-0.160.96-0.440.96-0.430.74-0.91-0.830.640.860.910.950.680.970.860.71-0.49-0.5
0.790.150.7-0.680.81-0.80.87-0.78-0.550.260.80.880.590.710.520.540.71-0.73-0.85
-0.660.25-0.60.16-0.630.38-0.580.510.32-0.28-0.69-0.73-0.51-0.76-0.36-0.32-0.49-0.730.67
-0.79-0.12-0.490.73-0.650.81-0.790.560.31-0.08-0.59-0.75-0.39-0.56-0.3-0.32-0.5-0.850.67
Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

201720182019202020212022 (projected)
Receivables971.5 M987.86 M861.03 M866.82 M780.14 M737.36 M
Accounts Payable194.74 M176.51 M110.14 M121.2 M139.38 M156.14 M
Accumulated Other Comprehensive Income18.79 M(32.73 M)(2.55 M)11.66 M13.41 M14.47 M
Total Assets5.35 B5.29 B6.34 B6.51 B7.49 B7.04 B
Current Assets1.72 B1.68 B2.07 B2.07 B1.86 B1.85 B
Assets Non Current3.63 B3.62 B4.27 B4.44 B5.11 B4.59 B
Cash and Equivalents519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Cash and Equivalents USD519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Deferred Revenue132.41 M118.18 M126.84 M237.37 M272.98 M233.37 M
Shareholders Equity3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Shareholders Equity USD3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Goodwill and Intangible Assets2.71 B2.67 B2.87 B2.88 B3.31 B3.12 B
Total Liabilities1.86 B1.75 B2.68 B2.88 B3.31 B2.86 B
Current Liabilities1.29 B1.21 B1.22 B1.3 B1.5 B1.49 B
Liabilities Non Current560.82 M542.43 M1.46 B1.57 B1.81 B1.95 B
Trade and Non Trade Payables194.74 M176.51 M110.14 M1.01 B1.16 B1.25 B
Property Plant and Equipment Net496.58 M525.31 M903.45 M931.93 M1.07 B1.16 B
Trade and Non Trade Receivables971.5 M987.86 M861.03 M866.82 M996.84 M984.27 M
Accumulated Retained Earnings Deficit4.67 B5.01 B5.34 B5.85 B6.73 B5.93 B
Tax Liabilities219.42 M224.57 M207.51 M258.49 M232.64 M240.95 M

Amdocs Investors Sentiment

The influence of Amdocs' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amdocs. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Amdocs' public news can be used to forecast risks associated with investment in Amdocs. The trend in average sentiment can be used to explain how an investor holding Amdocs can time the market purely based on public headlines and social activities around Amdocs Limited. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Amdocs' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amdocs' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amdocs' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Amdocs.

Amdocs Implied Volatility

    
  45.45  
Amdocs' implied volatility exposes the market's sentiment of Amdocs Limited stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amdocs' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amdocs stock will not fluctuate a lot when Amdocs' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amdocs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amdocs' short interest history, or implied volatility extrapolated from Amdocs options trading.
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.089
Market Capitalization
10.8 B
Quarterly Revenue Growth YOY
0.088
Return On Assets
0.0605
Return On Equity
0.15
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.